🔎 Trials Near Me

Avaleht › Ülekaalulisus › Florida › Orlando

Ülekaalulisus kliinilised uuringud linnas Orlando, FL

27 uuringut haiguse Ülekaalulisus jaoks otsivad osalejaid linnas Orlando ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.

Ametlik uuringutekst (inglise keeles)

Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

VärbamineFaas 2
  • Charter Research - Winter Park /ID# 281968, Orlando
  • Florida Institute For Clinical Research /ID# 282739, Orlando
Vanused 18–75 · Kõik sood · Uuendatud 2. okt 2026 · NCT07752979

Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients

Värbamine
  • Orlando Health, Inc., Orlando
Vanused 21–65 · Kõik sood · Uuendatud 1. okt 2026 · NCT07090005

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

VärbamineFaas 1Terved vabatahtlikud oodatud
  • Kailera Clinical Site, Orlando
Vanused 18–85 · Kõik sood · Uuendatud 1. okt 2026 · NCT07793929

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

VärbamineFaas 3
  • Florida Institute for Clinical Research, LLC, Orlando
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07533175

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

VärbamineFaas 2
  • Clinical Site Partners, LLC DBA Flourish Research, Winter Park · 5 mi kaugusel
  • K2 Medical Research Maitland LLC, Main Office, Maitland · 6 mi kaugusel
Vanused 18 ja vanemad · Kõik sood · Uuendatud 29. sept 2026 · NCT07685808

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

VärbamineFaas 2
  • Clinical Neuroscience Solutions, Orlando
Vanused 18–75 · Kõik sood · Uuendatud 28. sept 2026 · NCT07837973

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

VärbamineFaas 3
  • Clinical Neuroscience Solution, Orlando
  • Florida Institute for Clinical Research, LLC, Orlando
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

VärbamineFaas 3
  • Florida Inst For Clin Res LLC, Orlando
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

VärbamineFaas 3
  • Headlands Research Orlando, Orlando
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07794579

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

VärbamineFaas 3
  • Orlando Health, Orlando
  • Digestive and Liver Center of Florida, Orlando
Vanused 18–70 · Kõik sood · Uuendatud 24. sept 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

VärbamineFaas 3
  • Florida Hospital- Center for Pediatric Research, Orlando
  • Nemours Children's Health, Orlando
Vanused 6–17 · Kõik sood · Uuendatud 24. sept 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

VärbamineFaas 3
  • Orlando Health, Orlando
  • Digestive and Liver Center of Florida, Orlando
Vanused 18–70 · Kõik sood · Uuendatud 24. sept 2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

VärbamineFaas 3
  • Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 mi kaugusel
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

VärbamineFaas 3
  • Research Site, Ocoee · 10 mi kaugusel
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

VärbamineFaas 3
  • West Orange Endocrinology, Ocoee · 10 mi kaugusel
Vanused 45–99 · Kõik sood · Uuendatud 22. sept 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

VärbamineFaas 3
  • Conquest Research, Winter Park · 5 mi kaugusel
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

VärbamineFaas 2
  • Charter Research - Winter Park, Orlando
Vanused 18–75 · Kõik sood · Uuendatud 22. sept 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

VärbamineFaas 3
  • AURORA-1 Clinical Site, Winter Park · 5 mi kaugusel
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

VärbamineFaas 3
  • AURORA-2 Clinical Site, Winter Park · 5 mi kaugusel
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT07743450

Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households

Värbamine
  • University of Central Florida, Orlando
Vanused 5–11 · Kõik sood · Uuendatud 14. sept 2026 · NCT07464015

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

VärbamineFaas 3Terved vabatahtlikud oodatud
  • ACCOMPLISH-2 Research Site, Ocoee · 10 mi kaugusel
Vanused 18–79 · Kõik sood · Uuendatud 11. sept 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

VärbamineFaas 2
  • Charter Research - Winter Park, Orlando
Vanused 18–75 · Kõik sood · Uuendatud 8. sept 2026 · NCT06143956

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

VärbamineFaas 3
  • Kailera Clinical Site, Orlando
  • Kailera Clinical Site, Orlando
Vanused 18 ja vanemad · Kõik sood · Uuendatud 3. sept 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

VärbamineFaas 3
  • Clinical Neuroscience Solutions - Orlando, Orlando
  • Combined Research Orlando Phase I IV, Orlando
  • Florida Institute for Clinical Research, Orlando
Vanused 18–99 · Kõik sood · Uuendatud 3. sept 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

VärbamineFaas 3
  • Florida Institute for Clinical Research, Orlando
  • Conquest Research - Winter Park, Winter Park · 5 mi kaugusel
Vanused 18–99 · Kõik sood · Uuendatud 3. sept 2026 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

VärbamineFaas 3
  • Clinical Neuroscience Solutions, Orlando
  • Florida Institute for Clinical Research, Orlando
Vanused 18–99 · Kõik sood · Uuendatud 27. aug 2026 · NCT07575399

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

VärbamineFaas 3
  • ACCOMPLISH-1 Research Site, Ocoee · 10 mi kaugusel
Vanused 18–79 · Kõik sood · Uuendatud 10. aug 2026 · NCT07654361

Ülekaalulisus uuringud teistes linnades

Muud uuringud linnas Orlando

Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.